CVRX

$1.58+14.49%visit website

CVRx, Inc.

Market Cap

$42M

Live price × SEC shares (Jul 30, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.77

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.7

TTM to Jun 2026 · revenue

P/B

2.1

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	14,690	16,024	14,769	15,705	61,188
Cost of revenue	1,937	2,199	1,888	1,981	8,005
Gross profit	12,753	13,825	12,881	13,724	53,183
Research & development	3,146	3,000	3,084	3,130	12,360
Selling, general & administrative	21,875	22,009	21,958	23,617	89,459
Total operating expenses	25,021	25,009	25,042	26,747	101,819
Operating income	(12,268)	(11,184)	(12,161)	(13,023)	(48,636)
Interest expense	1,480	1,417	1,551	1,578	6,026
Pretax income	(12,873)	(11,941)	(13,119)	(14,041)	(51,974)
Income tax	(3.00)	(7.00)	1.00	3.00	(6.00)
Net income	(12,870)	(11,934)	(13,120)	(14,044)	(51,968)
EPS (basic) ($)	(0.49)		(0.50)	(0.53)	(1.97)
EPS (diluted) ($)	(0.49)		(0.50)	(0.53)	(1.97)
Weighted avg. shares (basic)	26,169		26,356	26,515
Weighted avg. shares (diluted)	26,169		26,356	26,515

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 21 more quarters, back to Jun 2020, with Tormere Pro.

Corporate Events (8-K)

12 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Sep 21, 2026 accepted 8:13 PM ET	5.02Officer / director change	Document SEC ↗
Aug 11, 2026 accepted 11:09 AM ET	5.02Officer / director change	Document SEC ↗
Aug 6, 2026 accepted 8:11 PM ET	2.02Earnings release	Document SEC ↗
Jun 9, 2026 accepted 12:00 PM ET	5.02Officer / director change	Document SEC ↗
Jun 3, 2026 accepted 8:49 PM ET	5.07Shareholder vote	Document SEC ↗
May 11, 2026 accepted 8:10 PM ET	2.02Earnings release	Document SEC ↗
Apr 13, 2026 accepted 12:05 PM ET	2.02Earnings release8.01Other events	Document SEC ↗
Mar 3, 2026 accepted 10:15 PM ET	5.02Officer / director change	Document SEC ↗
Feb 12, 2026 accepted 9:21 PM ET	2.02Earnings release	Document SEC ↗
Jan 12, 2026 accepted 1:57 PM ET	1.01Material agreement	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

73%

W/W +21.3pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Buy Activity

Buy Velocity Score

3.61x

Avg Daily Buying (90d)

291 sh/day

Baseline Daily Buying

193 sh/day

Unique Buyers (90d)

Sell Activity

Sell Velocity Score

0.53x

Avg Daily Selling (90d)

14.5 sh/day

Baseline Daily Selling

65.4 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-13	2026-08-13	Binkowski Brent	CHIEF OPERATING OFFICER	Purchase	26.2K	$2.91	$76K	56.5K	View
2026-08-12	2026-08-13	Binkowski Brent	CHIEF OPERATING OFFICER	Sale	1,309	$2.55	$3K	30.3K	View
2026-03-02	2026-03-16	Adamson Philip B.	Chief Medical Officer	Sale	1,262	$7.90	$10K	61.6K	View
2026-03-02	2026-03-03	OASHEIM JARED	CHIEF FINANCIAL OFFICER	Sale	1,744	$7.90	$14K	96.7K	View
2026-03-02	2026-03-03	John Robert Allen	Chief Revenue Officer	Sale	3,964	$7.90	$31K	86.0K	View

1–5 of 9

1 / 2

Recent News

CVRx to Participate in Upcoming Investor Conferences

Yahoo · 2026-11-02

Two conference appearances will stream live in November, with CVRx management

Stock Titan · 2026-11-02

CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026

Yahoo · 2026-10-22

CVRx Reports Q2 2026 Results: Full Earnings Call Transcript

Benzinga · 2026-10-12

CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026

Yahoo Finance · 2026-09-29

CVRx Appoints John Landry as Chief Financial Officer

Yahoo Finance · 2026-09-21

CVRx Responds to Letter from Pointillist Family Office

Yahoo Finance · 2026-08-25

CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy

Yahoo Finance · 2026-08-24

Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer

Morningstar · 2026-08-24

Cantor cuts CVRx stock price target on sales execution challenges

Investing.com · 2026-08-17

CVRx (CVRX) Q2 2026 Earnings Call Transcript

Yahoo Finance · 2026-08-13

CVRx Announces Sales Leadership Transition

Yahoo Finance · 2026-08-11

CVRx Stock Is Falling Overnight: Here's What's Driving the Move

Benzinga · 2026-08-07

Earnings To Watch: CVRx Inc (CVRX) Q2 2026 -- GF Value Sees 142% Upside

Yahoo Finance · 2026-08-05

CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy

Yahoo Finance · 2026-05-18

Informational purposes only, not investment advice.

CVRX

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

CVRx, Inc. (CVRX)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-08-13	Binkowski Brent	P	26,223	$76,432.18
2026-08-12	Binkowski Brent	S	1,309	$3,338.21
2026-03-02	Adamson Philip B.	S	1,262	$9,973.21
2026-03-02	OASHEIM JARED	S	1,744	$13,781.44
2026-03-02	John Robert Allen	S	3,964	$31,325.51